Caroline Roussel-Maupetit
Nessuna posizione attualmente
Profilo
Caroline Roussel-Maupetit is the founder who has founded two companies.
In 1995, she founded Synt:em SA where she held the title of Chief Operations Officer until 2005.
In 2007, she founded Advicenne SA where she held the title of Operations Director & General Manager until 2020.
Ms. Roussel-Maupetit's former job was as a Marketing Manager at Proteine Performance.
She obtained an undergraduate degree from Université de Technologie de Compiègne.
Precedenti posizioni note di Caroline Roussel-Maupetit
Società | Posizione | Fine |
---|---|---|
ADVICENNE | Founder | 12/03/2020 |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Founder | 01/01/2005 |
Proteine Performance
Proteine Performance Medical SpecialtiesHealth Technology Part of Cystar, Proteine Performance is a French company that manufactures diagnostic products. The private company is based in Paris, France. Proteine Performance was acquired by Cystar on September 01, 1995 for $6.27 million. | Sales & Marketing | - |
Formazione di Caroline Roussel-Maupetit
Université de Technologie de Compiègne | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ADVICENNE | Health Technology |
Aziende private | 2 |
---|---|
Proteine Performance
Proteine Performance Medical SpecialtiesHealth Technology Part of Cystar, Proteine Performance is a French company that manufactures diagnostic products. The private company is based in Paris, France. Proteine Performance was acquired by Cystar on September 01, 1995 for $6.27 million. | Health Technology |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
- Borsa valori
- Insiders
- Caroline Roussel-Maupetit